Zeynep Burak

923 total citations
28 papers, 371 citations indexed

About

Zeynep Burak is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Zeynep Burak has authored 28 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in Zeynep Burak's work include Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Zeynep Burak is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (4 papers) and Sarcoma Diagnosis and Treatment (4 papers). Zeynep Burak collaborates with scholars based in Türkiye, United States and France. Zeynep Burak's co-authors include Jean‐Luc Moretti, Yusuf Duman, Gülçin Başdemir, Selçuk Erdem, Meltem Çağlar, Ahmet Memiş, Esin Emin Üstün, Yı́ldı́z Erhan, Zehra Özcan and Orazio Schillaci and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine Communications and Annals of Nuclear Medicine.

In The Last Decade

Zeynep Burak

26 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeynep Burak Türkiye 9 171 131 105 83 82 28 371
Alaa Kandil Egypt 9 117 0.7× 160 1.2× 131 1.2× 83 1.0× 51 0.6× 20 407
Teruhiko Takayama Japan 11 199 1.2× 131 1.0× 62 0.6× 95 1.1× 48 0.6× 49 394
Eduardo Nóbrega Pereira Lima Brazil 14 187 1.1× 134 1.0× 114 1.1× 139 1.7× 77 0.9× 43 514
Sharjeel Usmani Kuwait 10 193 1.1× 148 1.1× 98 0.9× 94 1.1× 43 0.5× 98 394
Y.T. Omar Kuwait 9 234 1.4× 200 1.5× 132 1.3× 70 0.8× 39 0.5× 15 419
Pervin Hürmüz Türkiye 12 109 0.6× 239 1.8× 61 0.6× 89 1.1× 53 0.6× 55 381
Douglas A. Murrey United States 9 199 1.2× 130 1.0× 80 0.8× 100 1.2× 42 0.5× 21 408
Yasuhiro Sasakawa Japan 11 315 1.8× 164 1.3× 132 1.3× 104 1.3× 52 0.6× 19 525
Mitsuhiro Takahashi Japan 12 94 0.5× 175 1.3× 85 0.8× 138 1.7× 54 0.7× 36 441
Alice M. Scheff United States 9 102 0.6× 94 0.7× 116 1.1× 152 1.8× 140 1.7× 14 429

Countries citing papers authored by Zeynep Burak

Since Specialization
Citations

This map shows the geographic impact of Zeynep Burak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeynep Burak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeynep Burak more than expected).

Fields of papers citing papers by Zeynep Burak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeynep Burak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeynep Burak. The network helps show where Zeynep Burak may publish in the future.

Co-authorship network of co-authors of Zeynep Burak

This figure shows the co-authorship network connecting the top 25 collaborators of Zeynep Burak. A scholar is included among the top collaborators of Zeynep Burak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeynep Burak. Zeynep Burak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gündoğdu, Evren, et al.. (2023). 68Ga‐labeled, imatinib encapsulated, theranostic liposomes: Formulation, characterization, and in vitro evaluation of anticancer activity. Drug Development Research. 85(1). e22136–e22136. 6 indexed citations
2.
Burak, Zeynep, et al.. (2023). What has changed in the last 25 years in osteosarcoma treatment? A single center experience. The Turkish Journal of Pediatrics. 65(1). 54–63. 1 indexed citations
3.
Bozkurt, Murat Fani, et al.. (2020). Procedur Guideline for Lymphoscintigraphy and Sentinel Lymph Node in Breast Cancer. 6(3). 321–338. 1 indexed citations
4.
Eraslan, Cenk, et al.. (2018). Unexpected False-positive I-131 Uptake in Patients with Differentiated Thyroid Carcinoma. Molecular Imaging and Radionuclide Therapy. 27(3). 99–106. 11 indexed citations
5.
Çok, Gürsel, et al.. (2006). Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Annals of Nuclear Medicine. 20(4). 269–275. 16 indexed citations
6.
Moretti, Jean‐Luc, et al.. (2005). To use MIBI or not to use MIBI? That is the question when assessing tumour cells. European Journal of Nuclear Medicine and Molecular Imaging. 32(7). 836–842. 43 indexed citations
7.
Burak, Zeynep, et al.. (2003). 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.. PubMed. 44(9). 1394–401. 36 indexed citations
8.
Burak, Zeynep, et al.. (2002). The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer. Annals of Nuclear Medicine. 16(2). 103–108. 14 indexed citations
9.
Kantar, Mehmet, Nazan Çetingül, Savaş Kansoy, et al.. (2002). TREATMENT RESULTS OF OSTEOSARCOMA OF THE EXTREMITY IN CHILDREN AND ADOLESCENTS AT EGE UNIVERSITY HOSPITAL. Pediatric Hematology and Oncology. 19(7). 475–482. 3 indexed citations
10.
Burak, Zeynep, et al.. (2001). The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response. European Journal of Nuclear Medicine and Molecular Imaging. 28(9). 1341–1350. 26 indexed citations
11.
Özcan, Zehra, et al.. (2001). Correlation of 99mTc-sestamibi uptake with blood-pool and osseous phase 99mTc-MDP uptake in malignant bone and soft-tissue tumours. Nuclear Medicine Communications. 22(6). 679–683. 5 indexed citations
12.
Özcan, Zehra, et al.. (1999). False-Negative Scintigraphy With Tc-99m Sestamibi in Stage IV Neuroblastoma. Clinical Nuclear Medicine. 24(4). 267–270.
13.
Burak, Zeynep, et al.. (1999). The role of 99Tcm-sestamibi scintigraphy in the staging and prediction of the therapeutic response of stage IV neuroblastoma. Nuclear Medicine Communications. 20(11). 991–1000. 3 indexed citations
14.
Özcan, Zehra, et al.. (1999). Assessment of chemotherapy-induced changes in bone sarcomas. Nuclear Medicine Communications. 20(1). 41–48. 6 indexed citations
15.
Burak, Zeynep, et al.. (1998). The role of 99Tcm-tetrofosmin myocardial perfusion scintigraphy in the assessment of patients with previous myocardial infarction. Nuclear Medicine Communications. 19(2). 127–136. 2 indexed citations
16.
Özcan, Zehra, Zeynep Burak, Coşkun Özcan, et al.. (1996). Is 201Tl a reliable agent in tumour imaging?. Nuclear Medicine Communications. 17(9). 805–809. 6 indexed citations
17.
Duman, Yusuf, et al.. (1995). Clinical evaluation of metastases of malignant melanoma imaging with 99Tcm-glutathione and 99Tcm-anti-melanoma antibody. Nuclear Medicine Communications. 16(11). 927–935. 7 indexed citations
18.
Yazıcı, Muharrem, et al.. (1995). Thallium-201 Uptake in Myositis Ossificans Potential Pitfall in Diagnosis. Clinical Nuclear Medicine. 20(3). 259–262. 5 indexed citations
19.
Burak, Zeynep, Ahmet Memiş, Selçuk Erdem, et al.. (1994). Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. Nuclear Medicine Communications. 15(8). 604–612. 74 indexed citations
20.
Duman, Yusuf, et al.. (1993). The value and limitations of 201T1 scintigraphy in the evaluation of lung lesions and post-therapy follow-up of primary lung carcinoma. Nuclear Medicine Communications. 14(6). 446–453. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaa Kandil Breakdown of academic impact, for papers by Teruhiko Takayama Breakdown of academic impact, for papers by Eduardo Nóbrega Pereira Lima Breakdown of academic impact, for papers by Sharjeel Usmani Breakdown of academic impact, for papers by Y.T. Omar Breakdown of academic impact, for papers by Pervin Hürmüz Breakdown of academic impact, for papers by Douglas A. Murrey Breakdown of academic impact, for papers by Yasuhiro Sasakawa Breakdown of academic impact, for papers by Mitsuhiro Takahashi Breakdown of academic impact, for papers by Alice M. Scheff
Rankless by CCL
2026